Pelthos Therapeutics Inc. (PTHS)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pelthos Therapeutics Inc.’s names, not what it holds today.
0 published
2 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Apr 28, 2020 | 10,633,399 | Functionalized aminobenzoboroxoles | Organic fine chemistry | Channel Therapeutics, Inc. |
| Jul 30, 2019 | 10,364,253 | Salinomycin derivatives and therapeutic uses thereof | Pharmaceuticals | Channel Therapeutics, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Feb 13, 2025 | 2025/0049841 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | Pharmaceuticals | LNHC, INC. |
| Aug 16, 2018 | 2018/0230169 | FUNCTIONALIZED AMINOBENZOBOROXOLES | Organic fine chemistry | Channel Therapeutics, Inc. · patent 10,633,399 granted from it |
| Aug 16, 2018 | 2018/0230163 | SALINOMYCIN DERIVATIVES AND THERAPEUTIC USES THEREOF | Pharmaceuticals | Channel Therapeutics, Inc. · patent 10,364,253 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.